Relmada Therapeutics, Inc.
NASDAQ:RLMD · NASDAQ Global Select
+$0.13 today
Vol 2.02M · Avg 1.21M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+830.40%
Period High
$7.86
Period Low
$0.54
Latest
$6.55
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Immunic, Inc.
NASDAQ:IMUX
$136.78M
Vaxart, Inc.
NASDAQ:VXRT
$135.55M
Repare Therapeutics Inc.
RPTX
$114.24M
Fortress Biotech, Inc.
NASDAQ:FBIO
$92.02M
Adicet Bio, Inc.
NASDAQ:ACET
$75.25M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$59.20M
Cibus, Inc.
NASDAQ:CBUS
$55.95M
TScan Therapeutics, Inc.
NASDAQ:TCRX
$55.71M
Acrivon Therapeutics, Inc. Common Stock
ACRV
$46.70M
Lite Strategy, Inc.
LITS
$25.22M
What is the latest RLMD filing?
The latest filing shown is SC 13G dated Jun 9, 2026.
How many recent filings does RLMD have?
Intrinsic Alpha currently shows 20 recent filings for RLMD.
Explore More
Continue the stock analysis
Jump to another research area for this company.